CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ...

CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access ...

Regulators have lifted the clinical hold on Intellia Therapeutics' MAGNITUDE-2 study, allowing the trial to resume. The company has updated the study protocol, including a higher patient enrollment ...

Protocol Behavioral Health ("Protocol") today announced its official public launch, bringing oncology-specific behavioral health and supportive care directly into oncology practices and cancer clinics ...

"Gene editing takes centre stage in FDA’s new rare disease approval pathway" was originally created and published by ...

Companies developing therapies for rare diseases could find it easier to bring their treatments to market after the FDA ...

Support vector machines improve classification by mapping inseparable signals into higher-dimensional spaces. Random forest models, through ensemble decision trees, increase robustness against ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) ranks among the best innovative stocks to buy according to Wall Street analysts. H.C. Wainwright reiterated a Buy rating on Intellia Therapeutics, Inc.

Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...

Chemistry World provides expert, independent science journalism for the global chemical science community. We are part of the ...

Mitochondria possess their own mRNA translation system, mediated by specialized mitoribosomes. Dysregulation of mitochondrial translation disrupts metabolic homeostasis and is linked to various ...